Cargando…

Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States

BACKGROUND: New therapies for castration-resistant prostate cancer (CRPC) may be associated with increased risk of second primary malignancies (SPM). We therefore estimated the population-based incidence of SPM among patients with CRPC in the Surveillance, Epidemiology, and End Results (SEER)-Medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saltus, Catherine W., Vassilev, Zdravko P., Zong, Jihong, Calingaert, Brian, Andrews, Elizabeth B., Soriano-Gabarró, Montse, Kaye, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388338/ https://www.ncbi.nlm.nih.gov/pubmed/30886751 http://dx.doi.org/10.1155/2019/4387415

Ejemplares similares

Corrigendum to “Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States”
por: Saltus, Catherine W., et al.
Publicado: (2019)

Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US
por: Kawai, Alison Tse, et al.
Publicado: (2019)

Overall survival and second primary malignancies in men with metastatic prostate cancer
por: Mehtälä, Juha, et al.
Publicado: (2020)

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
por: Johannes, Catherine B., et al.
Publicado: (2022)

Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network
por: Soriano, Lucía Cea, et al.
Publicado: (2018)

Prostate cancer with bone metastasis in Beijing: an observational study of prevalence, hospital visits and treatment costs using data from an administrative claims database
por: Zhuo, Lin, et al.
Publicado: (2019)

Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom
por: Cea Soriano, Lucía, et al.
Publicado: (2015)

Incidence of Second Malignancies for Prostate Cancer
por: Van Hemelrijck, Mieke, et al.
Publicado: (2014)

Association Between Low-Dose Aspirin Use and Colorectal Cancer Incidence in Taiwan
por: Lin, Hui-Min Diana, et al.
Publicado: (2020)

Low‐dose aspirin and risk of gastric and oesophageal cancer: A population‐based study in the United Kingdom using The Health Improvement Network
por: García Rodríguez, Luis A., et al.
Publicado: (2020)

Epidemiology of Adult Soft-Tissue Sarcomas in Germany
por: Saltus, Catherine W., et al.
Publicado: (2018)

Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
por: García Rodríguez, Luis A., et al.
Publicado: (2019)

Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
por: Vora, Pareen, et al.
Publicado: (2016)

The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice
por: Cea Soriano, Lucía, et al.
Publicado: (2016)

Validation of low‐dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over‐the‐counter use?
por: Cea Soriano, Lucía, et al.
Publicado: (2015)

Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
por: García Rodríguez, Luis A., et al.
Publicado: (2020)

The reporting and diagnosis of uterine fibroids in the UK: an observational study
por: Martín-Merino, Elisa, et al.
Publicado: (2016)

Long-Term Adherence and Persistence to Low-Dose Aspirin for the Prevention of Cardiovascular Disease: A Population-Based Cohort Study
por: Vora, Pareen, et al.
Publicado: (2022)

Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
por: Hasegawa, Kanae, et al.
Publicado: (2021)

New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case–control study in UK general practice
por: García Rodríguez, Luis A., et al.
Publicado: (2017)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
por: Paller, Channing J, et al.
Publicado: (2011)

Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
por: Rice, Meghan A., et al.
Publicado: (2019)

The second docetaxel rechallenge for metastatic castration-resistant prostate cancer: a case report
por: Ning, Wei, et al.
Publicado: (2023)

Castration for Prostatic Hypertrophy
Publicado: (1899)

A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies
por: Vora, Pareen, et al.
Publicado: (2018)

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
por: Kregel, Steven, et al.
Publicado: (2016)

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
por: Saad, Fred, et al.
Publicado: (2021)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
por: Davis, Keith L., et al.
Publicado: (2015)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

The impact of childhood acute rotavirus gastroenteritis on the parents’ quality of life: prospective observational study in European primary care medical practices
por: Domingo, Javier Diez, et al.
Publicado: (2012)

Incidence and associated factors of developing second pelvic malignant neoplasms among prostate cancer patients treated with radiotherapy
por: Wang, Youbiao, et al.
Publicado: (2023)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
por: Kita, Yuki, et al.
Publicado: (2018)

Breast Metastasis From Castrate-Resistant Prostatic Adenocarcinoma Mimicking as a Second Primary: A Case Report
por: Lima, Valerie, et al.
Publicado: (2020)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

A Case of Castration for Hypertrophied Prostate
Publicado: (1897)

Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives
por: Zheng, Guoqiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m9r3r3cnv5oi7sdudpqffe1r9q